Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial.

Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial. JAMA. 2022 01 11; 327(2):138-150.

View in: PubMed

subject areas

Body Weight
Diabetes Mellitus
Diet Therapy
Drug Administration Schedule
Exercise
Female
Glucagon-Like Peptides
Humans
Hypoglycemic Agents
Injections, Subcutaneous
Liraglutide
Male
Middle Aged
Obesity
Odds Ratio
Overweight
Patient Dropouts
Placebos
Treatment Outcome
United States
Weight Loss

authors with profiles

Patrick M O'Neil
W. Timothy Garvey